Validea’s guru fundamental report for EXACT SCIENCES CORP (EXAS) shows that it rates highest using the P/B Growth Investor model based on Partha Mohanram’s strategy. This large-cap growth stock in the Biotechnology & Drugs industry has a rating of 66% based on its underlying fundamentals and valuation. The strategy looks for low book-to-market stocks with potential for sustained growth. The stock meets most of the criteria for this strategy, except for advertising, capital expenditures, and research and development to assets ratio. Partha Mohanram is known for his research on growth investing and value investing.

Read more at Nasdaq: EXAS Quantitative Stock Analysis | Nasdaq